483
Roche Molecular Systems, Inc.FDA 483 - Roche Molecular Systems, Inc. - December 08, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Roche Molecular Systems, Inc. in Branchburg, NJ, received a Form 483 with two observations. The firm failed to report a biological product deviation for an IVD kit with internal control invalidations caused by a software error during the filling process. Additionally, the firm did not adequately evaluate a supplier, which resulted in numerous customer complaints about leaking reagent bottles.
Open in Dashboard
ID · a25a7c49-4521-4b0a-813b-71436327812d